Ledger.Open graph →
SEC Form D · filed April 23, 2019

DTx Pharma, Inc

Offering
$7.0M
Sold
$5.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Jeffrey T. Friedman · San Diego, CADirectorJohn T. Grundy · San Diego, CADirectorArthur T. Suckow · San Diego, CAExec · DirectorHigh Traverse Development, LLC · Salt Lake City, UTDirectorDaniel C. Davis · Campbell, CAExec · DirectorSanket Wani · Malvern, PADirectorMichael J. Holmberg · Chicago, ILDirectorSam Konz · New York, NYExec · DirectorEric Felder · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗